What is the current capacity of nucleic acid detection reagents and equipment in China？ Ministry of Industry and Information Technology： There is a large surplus.

CCTV News:On August 5th, the State Council Press Office held a routine briefing on the State Council policy.Wang Jiangping, Vice Minister of the Ministry of Industry and Information Technology, Bao Xianhua, Director of the Division of Achievements Transformation and Regional Innovation of the Ministry of Science and Technology, Jiao Yahui, Inspector of the Medical Administration and Hospital Authority of the National Health and Wellness Commission, and Wang Lanming, Inspector of the Device Registration Department of the Food and Drug Administration, introduced the situation of improving Covid-19’s testing ability and answered questions from reporters.

In response to a reporter’s question, Wang Jiangping, Vice Minister of the Ministry of Industry and Information Technology, said that since the outbreak of the COVID-19 epidemic, according to the deployment of the CPC Central Committee, the medical material support group of the joint prevention and control mechanism in the State Council has continuously strengthened the research and development, registration and production of nucleic acid detection products, and related enterprises have also continuously stabilized production and expanded production capacity, constantly improving product quality, effectively meeting the needs of domestic epidemic prevention and control.

First, the production capacity has been greatly improved.After a period of continuous efforts, the weekly production capacity of nucleic acid detection reagents in China has reached 46.48 million, and the weekly production capacity of nucleic acid detection equipment has reached more than 1,200. With the normalization of epidemic prevention and control, the demand for nucleic acid detection equipment and reagents has decreased. At present, the weekly output of reagents is 15 million, and the weekly output of equipment is 660, so there is a large surplus in production capacity.

The second is to effectively promote the docking of supply and demand.Through the medical material support and dispatching platform, we have promoted the docking of the supply and demand sides of nucleic acid detection reagents and equipment. By the end of July, nearly 200 million copies of nucleic acid detection reagents and more than 12,000 sets of equipment have been sent to hospitals, centers for disease control and prevention, customs ports and third-party testing institutions at all levels across the country.

The third is to ensure the prevention and control needs at different stages.According to the requirements of the CPC Central Committee and the State Council, we have made every effort to ensure the universal inspection in Wuhan and the epidemic prevention and control needs in Northeast China, Beijing, Xinjiang and other places, so as to achieve "all inspection should be done", which provided a solid guarantee for the resumption of work and the normalization of epidemic prevention and control throughout the country.

Generally speaking, the production capacity of nucleic acid detection reagents and equipment in China can meet the needs of current normalized epidemic prevention and control. At the same time, however, the spread of overseas epidemics is still continuing, and clustered epidemics occur from time to time in some areas of China. Moreover, autumn and winter are coming, international routes are being resumed one after another, and the situation of foreign defense input and internal defense rebound is still grim. We should keep the hard-won epidemic prevention achievements, strengthen the research and judgment of epidemic situation, actively carry out demand forecasting, continuously ensure the stability of production capacity, and be prepared to increase production capacity reserves in extreme cases.